Insulet Corporation
Nasdaq PODD · Acton, MA
Works in Immunology · Metabolic & endocrine
Insulet Corporation is a clinical trial sponsor based in Acton, MA, listed as Nasdaq PODD. It has 6 active clinical trials with 3,286 planned participants, in Immunology and Metabolic & endocrine. Since 2021 it has completed 15 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq PODD
Pipeline · 6 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Insulet Corporation
Insulet Corporation is lead sponsor of 6 active clinical trials on ClinicalTrials.gov, with 3,286 planned participants, in Immunology, Metabolic & endocrine. Since 2021 it has completed 15 trials and stopped 0 early.
Insulet Corporation is based in Acton, MA and is listed as Nasdaq PODD. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Insulet Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-10.
Approve Suite is not affiliated with Insulet Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.